Hepatology Lectures

DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: Post-transplant: Who and When?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Robert Brown
- 2014 ILTS/ELITA/LICAGE London
DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: A Lead into Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Marina Berenguer
- 2014 ILTS/ELITA/LICAGE London
PERIOPERATIVE MANAGEMENT CONTROVERSIES: Management of the Living Donor Recipient

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Anes/CCM
- Akila Rajakumar
- 2014 ILTS/ELITA/LICAGE London
EXTREMES OF THE IMMUNOLOGIC SPECTRUM: Etiology: Who Needs Less?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Federico G. Villamil
- 2014 ILTS/ELITA/LICAGE London
SURGICAL TECHNIQUES: Latest Surgical Innovation in LDLT

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatology
- Sung-gyu Lee
- 2014 ILTS/ELITA/LICAGE London
LIVING DONOR: Improving Living Donor Safety

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Anes/CCM
- Daniela Ladner
- 2014 ILTS/ELITA/LICAGE London
LIVING DONOR: Are There Any Contraindications To Living Donor Liver Transplant?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Anes/CCM
- Chung Mau Lo
- 2014 ILTS/ELITA/LICAGE London
PEDIATRIC: Paediatric Liver Allocation around the World – Europe & Discussion

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Registries / regulation / resources
- Raj Prasad
- 2014 ILTS/ELITA/LICAGE London
PEDIATRIC: Pediatric Liver Allocation Around the World – South America

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Registries / regulation / resources
- Joao Seda Neto
- 2014 ILTS/ELITA/LICAGE London
PEDIATRIC: Liver Allocation in North America

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Registries / regulation / resources
- Binita M. Kamath
- 2014 ILTS/ELITA/LICAGE London
PEDIATRIC: Liver Transplantation for a Newborn

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Mureo Kasahara
- 2014 ILTS/ELITA/LICAGE London
PEDIATRIC: What you Need to Know About an Adult Recipient with Paediatric Liver Disease

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Surgical aspects / complications
- Nigel Heaton
- 2014 ILTS/ELITA/LICAGE London
HCC: Time for New Criteria in an Era of Effective Loco-Regional Therapy

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatocellular carcinoma
- John Paul Roberts
- 2014 ILTS/ELITA/LICAGE London
HCC: Impact of Rationing on Allocation for HCC

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatocellular carcinoma
- Pierre-alain Clavien
- 2014 ILTS/ELITA/LICAGE London
HCC: Liver Transplantation for HCC

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Christophe Duvoux
- 2014 ILTS/ELITA/LICAGE London
HCC: Containing the Demand of Liver Transplantation for HCC

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatocellular carcinoma
- Vincenzo Mazzaferro
- 2014 ILTS/ELITA/LICAGE London
RISK EVALUATION AND OUTCOMES: Impact of Early Post-operative Morbidity on Long-term Patient Outcomes

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Donor selection / management / DCD
- Gareth Ackland
- 2014 ILTS/ELITA/LICAGE London
RISK EVALUATION AND OUTCOMES: Composite Risk: Predicting Short and Long Term Outcomes

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Susan Mandell
- 2014 ILTS/ELITA/LICAGE London
PRACTICE GUIDELINES:: A Draft ILTS Guideline for Living Donor Liver Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Anes/CCM
- Charles Miller
- 2014 ILTS/ELITA/LICAGE London
VANGUARD DEBATE: Which Grafts Can Truly be Considered Marginal in 2014? — Con

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Donor selection / management / DCD
- Mohamed Rela
- 2014 ILTS/ELITA/LICAGE London
VANGUARD DEBATE: Liver Transplantation for HCC and Transplant Benefit — Con

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatocellular carcinoma
- Richard B. Freeman
- 2014 ILTS/ELITA/LICAGE London
VANGUARD DEBATE: Liver Transplantation for HCC and Transplant Benefit — Pro

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatocellular carcinoma
- Alessandro Vitale
- 2014 ILTS/ELITA/LICAGE London
VANGUARD GRAND ROUND CASE PRESENTATIONS: Use of New Antiviral Therapies Before and After Liver Transplantation for HCV?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Patrizia Burra
- 2014 ILTS/ELITA/LICAGE London
VANGUARD GRAND ROUND CASE PRESENTATIONS: Late Graft Dysfunction and Donor Specific Antibodies Discussion

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Donor selection / management / DCD
- Goran B. Klintmalm
- 2014 ILTS/ELITA/LICAGE London
Clinical Practice: Risk Factors and Treatment of DVT in Patients with Cirrhosis

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Patrick Northup
- 2013 Coagulopathy in Liver Disease - Padua
Introduction & Basic Science: The History of Haemostasis

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Complications
- P M Mannucci
- 2013 Coagulopathy in Liver Disease - Padua
STATE-OF-THE-ART LECTURE: HBV in New Zealand – From Community Screening to Liver Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis B
- Ed Gane
- 2013 ILTS Sydney
LIVER TOLERANCE IN TRANSPLANTATION: Operational Tolerance in Pediatric and Adult Liver Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Pediatric liver transplantation
- Minnie Sarwal
- 2013 ILTS Sydney
IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: Combined Liver Kidney for HRS – Con

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Renal
- Steve Chadban
- 2013 ILTS Sydney
IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: It is all CNI Toxicity – Con

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Renal
- John O’grady
- 2013 ILTS Sydney
IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: It is all CNI Toxicity – Pro

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Renal
- Brian J. Nankivell
- 2013 ILTS Sydney
IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: Switch or Minimize CNI?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Renal
- Paolo De Simone
- 2013 ILTS Sydney
SURGICAL TECHNIQUES: What Happens When You Can~t Operate – The Hurricane Sandy Experience

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Lewis Teperman
- 2013 ILTS Sydney
ACUTE LIVER FAILURE: Living Donation for Acute Liver Failure

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Acute Liver Failure
- Avi S. Soin
- 2013 ILTS Sydney
MAXIMIZING OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: Should We Ignore Antibody Cross Matches?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Pediatric liver transplantation
- Laura J. Wozniak
- 2013 ILTS Sydney
MAXIMIZING OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: Protocol Liver Biopsies: Do They Alter Outcomes?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Pathology / imaging
- Helen M. Evans
- 2013 ILTS Sydney
MAXIMIZING OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: Neurodevelopmental Outcomes after Pediatric Liver Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Pediatric liver transplantation
- Vicky Lee Ng
- 2013 ILTS Sydney
HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: Interferon-free Regimens Pre- and Post-Transplant

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Michael Charlton
- 2013 ILTS Sydney
HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: Triple Therapy with Boceprevir/Telaprevir Before and After Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Professor Didier Samuel
- 2013 ILTS Sydney
HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: What are the Key Influences on Outcome in the Pre-DAA Era?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Marina Berenguer
- 2013 ILTS Sydney

« Previous 1 … 4 5 6 7 Next »

International Liver Transplantation Society

Hepatology Lectures

DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: Post-transplant: Who and When?

DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: A Lead into Transplantation

PERIOPERATIVE MANAGEMENT CONTROVERSIES: Management of the Living Donor Recipient

EXTREMES OF THE IMMUNOLOGIC SPECTRUM: Etiology: Who Needs Less?

SURGICAL TECHNIQUES: Latest Surgical Innovation in LDLT

LIVING DONOR: Improving Living Donor Safety

LIVING DONOR: Are There Any Contraindications To Living Donor Liver Transplant?

PEDIATRIC: Paediatric Liver Allocation around the World – Europe & Discussion

PEDIATRIC: Pediatric Liver Allocation Around the World – South America

PEDIATRIC: Liver Allocation in North America

PEDIATRIC: Liver Transplantation for a Newborn

PEDIATRIC: What you Need to Know About an Adult Recipient with Paediatric Liver Disease

HCC: Time for New Criteria in an Era of Effective Loco-Regional Therapy

HCC: Impact of Rationing on Allocation for HCC

HCC: Liver Transplantation for HCC

HCC: Containing the Demand of Liver Transplantation for HCC

RISK EVALUATION AND OUTCOMES: Impact of Early Post-operative Morbidity on Long-term Patient Outcomes

RISK EVALUATION AND OUTCOMES: Composite Risk: Predicting Short and Long Term Outcomes

PRACTICE GUIDELINES:: A Draft ILTS Guideline for Living Donor Liver Transplantation

VANGUARD DEBATE: Which Grafts Can Truly be Considered Marginal in 2014? — Con

VANGUARD DEBATE: Liver Transplantation for HCC and Transplant Benefit — Con

VANGUARD DEBATE: Liver Transplantation for HCC and Transplant Benefit — Pro

VANGUARD GRAND ROUND CASE PRESENTATIONS: Use of New Antiviral Therapies Before and After Liver Transplantation for HCV?

VANGUARD GRAND ROUND CASE PRESENTATIONS: Late Graft Dysfunction and Donor Specific Antibodies Discussion

Clinical Practice: Risk Factors and Treatment of DVT in Patients with Cirrhosis

Introduction & Basic Science: The History of Haemostasis

STATE-OF-THE-ART LECTURE: HBV in New Zealand – From Community Screening to Liver Transplantation

LIVER TOLERANCE IN TRANSPLANTATION: Operational Tolerance in Pediatric and Adult Liver Transplantation

IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: Combined Liver Kidney for HRS – Con

IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: It is all CNI Toxicity – Con

IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: It is all CNI Toxicity – Pro

IMPROVING RENAL FUNCTION OUTCOMES POSTLIVER TRANSPLANTATION: Switch or Minimize CNI?

SURGICAL TECHNIQUES: What Happens When You Can~t Operate – The Hurricane Sandy Experience

ACUTE LIVER FAILURE: Living Donation for Acute Liver Failure

MAXIMIZING OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: Should We Ignore Antibody Cross Matches?

MAXIMIZING OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: Protocol Liver Biopsies: Do They Alter Outcomes?

MAXIMIZING OUTCOMES IN PEDIATRIC LIVER TRANSPLANTATION: Neurodevelopmental Outcomes after Pediatric Liver Transplantation

HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: Interferon-free Regimens Pre- and Post-Transplant

HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: Triple Therapy with Boceprevir/Telaprevir Before and After Transplantation

HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: What are the Key Influences on Outcome in the Pre-DAA Era?

Specialty Sections

Content Directories